Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design

Lisa Daniel-Fischer; Marlies Antlanger; Daniel Cejka; Kathrin Eller; Philipp Gauckler; Balazs Odler; Martin Windpessl; null et al.

doi:10.1016/j.ekir.2023.10.027

Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design

Lisa Daniel-Fischer, Marlies Antlanger, Daniel Cejka, Kathrin Eller, Philipp Gauckler, Balazs Odler, Martin Windpessl, et al.

Department of Internal Medicine 2 - Gastroenterology and Hepatology, Endocrinology and Metabolism, Nephrology, Rheumatology

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	478-481
Number of pages	4
Journal	Kidney International Reports
Volume	9
Issue number	2
DOIs	https://doi.org/10.1016/j.ekir.2023.10.027
Publication status	Published - Feb 2024

Fields of science

303 Health Sciences
304 Medical Biotechnology
305 Other Human Medicine, Health Sciences
301 Medical-Theoretical Sciences, Pharmacy
302 Clinical Medicine

Access to Document

10.1016/j.ekir.2023.10.027

Cite this

@article{dbfeb9e6d19d4661a14a2437f320952c,

title = "Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design",

author = "Lisa Daniel-Fischer and Marlies Antlanger and Daniel Cejka and Kathrin Eller and Philipp Gauckler and Balazs Odler and Martin Windpessl and {et al.}",

year = "2024",

month = feb,

doi = "10.1016/j.ekir.2023.10.027",

language = "English",

volume = "9",

pages = "478--481",

journal = "Kidney International Reports",

issn = "2468-0249",

number = "2",

}

TY - JOUR

T1 - Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design

AU - Daniel-Fischer, Lisa

AU - Antlanger, Marlies

AU - Cejka, Daniel

AU - Eller, Kathrin

AU - Gauckler, Philipp

AU - Odler, Balazs

AU - Windpessl, Martin

AU - et al., null

PY - 2024/2

Y1 - 2024/2

UR - https://www.kireports.org/article/S2468-0249(23)01569-3/fulltext

UR - http://www.scopus.com/inward/record.url?scp=85180340521&partnerID=8YFLogxK

U2 - 10.1016/j.ekir.2023.10.027

DO - 10.1016/j.ekir.2023.10.027

M3 - Article

C2 - 38344717

SN - 2468-0249

VL - 9

SP - 478

EP - 481

JO - Kidney International Reports

JF - Kidney International Reports

IS - 2

ER -

Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design

Fields of science

Access to Document

Other files and links

Cite this